Scholars Conferences is a global leader in producing high quality Conferences, Meetings, Workshops, Symposia and Webinars in all major fields of Pharma, Healthcare, Science, Technology and Medicine.

Infectious Disease 2020 is the 2nd Edition of Scholars International Conference on Infectious Diseases going to be held during September 14-15, 2020 at Rome, Italy. Infectious Disease 2020, which is the leading event for those interested in Infectious Diseases, Microbiology and Immunology, brings together professionals in the field to raise global awareness and improve standards of diagnosis, prevention and treatment.

Main theme of the conference is “Novel Trends and Evolution in Infectious Diseases Research”. Infectious Diseases 2020 aims at sharing new ideas and new technologies amongst the professionals, industrialists and students from research areas of Infectious Diseases, Bacterial and Viral Infections and their Therapies to share their recent innovations and applications and indulge in interactive discussions and technical sessions at the event.

Over 100 delegates representing leading Universities, Colleges, Institutes, Organizations, Companies, internationally renowned research & academic institutions will be present at the prestigious conference.

Infectious Diseases 2020 has a global concern on Epidemics of influenza, Ebola, and cholera cause significant morbidity and mortality while limiting economies and public health practices.

Although progress has been made in the sphere of infectious diseases with the World Health Organization (WHO) estimating the number of overall infectious disease attributable deaths falling from 12.1 million in 2000 to 9.5 million in 2012, there is still a crucial need for research efforts and healthcare delivery. Infectious diseases afflicted patients at young ages, resulting in deaths earlier in life when compared with other causes.

Multiple socioeconomic, environmental, and ecological factors converge to impede positive health outcomes for patients and their communities. Emerging infectious diseases, of which 75% originate in animal populations and cross the animal-human species barrier, require constant surveillance and reactive control techniques.

Further compounding these challenges is the development of antimicrobial resistance, reducing the number of effective treatment measures capable of restoring health. Collectively, these are just a few of the challenges that afflict patients and prevent progress in the healthcare community.

KEY STATS 

  • 25+ Interactive Sessions 
  • 20+ hours of networking events 
  • 10+ Keynote Speakers
  • 50+ Innovative Featured Speakers 
  • 5+ Workshops
  • 100+ Participants from Industry & Academia (50:50)